Skip to main content
Premium Trial:

Request an Annual Quote

Celera Licenses Protein IP for Lung Cancer Dx

NEW YORK (GenomeWeb News) – Celera said today that it has licensed the rights to use Medical Therapies Limited's patent portfolio for the protein midkine in its lung cancer diagnostics programs.

Under the exclusive license with Sydney-based Medical Therapies, Celera will pay up front and milestone payments and royalties on product sales over the life of the patents. Specific financial details were not disclosed by the firms.

Celera said it will use the midkine patents to develop and sell diagnostics for a range of lung cancer testing uses, including risk assessment, early detection, differentiation, prognosis, disease recurrence and progression, as well as response to treatment.

Clinical studies have found that blood midkine levels are greatly elevated in the early stages of cancer formation, Celera said. High midkine levels also have been linked to poor patient prognosis for a number of cancers, the company added.

"Celera has used a novel mass spectrometry-based approach to identify potential circulating protein biomarkers for non-small cell lung cancer," Steve Ruben, Celera's VP of proteomics, said in a statement. "We believe that midkine could have an important role in a blood-based immunodiagnostic assay."

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.